Periodic Reporting for period 1 - IN-3D-CAN (Instrumented 3D-Printed Miniature Muscles for Cardiotoxicity Screens of Cancer Therapies)

The extreme costs associated with drug development is largely caused by our inability to predict outcomes of clinical trials at an early stage. For instance, it has been estimated by retrospective analyses that merely ~50% of rodent studies are predictive of human toxicity...